Wu, Ziping
Zhang, Lei
Xu, Shuguang
Lin, Yanping
Yin, Wenjin
Lu, Jinglu
Sha, Rui
Sheng, Xiaonan
Zhou, Liheng
Lu, Jinsong http://orcid.org/0000-0003-3147-0702
Clinical trials referenced in this document:
Documents that mention this clinical trial
Predictive and prognostic value of ZEB1 protein expression in breast cancer patients with neoadjuvant chemotherapy
https://doi.org/10.1186/s12935-019-0793-2
How shall we treat early triple-negative breast cancer (TNBC): from the current standard to upcoming immuno-molecular strategies
https://doi.org/10.1136/esmoopen-2018-000357
Funding for this research was provided by:
National Natural Science Foundation of China (81172505, 818802626)
Foundation of Shanghai Municipal Commission of Health and Family Planning (201640006)
Science and Technology Commission of Shanghai Municipality (14411950202, 15JC1402700)
Nurturing Fund of Renji hospital (RJZZ15-023, RJZZ15-019, RJZZ16-023, PYZY16-018)
Shanghai Jiao Tong University Medical Engineering Cross Fund (YG2016QN52)
Incubating Program for Clinical Research and Innovation of Renji Hospital (PYII-17-006)
Article History
Received: 17 October 2018
Accepted: 20 March 2019
First Online: 29 March 2019